Midazolam to Lorazepam Conversion
5 mg of midazolam (Versed) is equivalent to approximately 2-2.5 mg of lorazepam (Ativan). 1
Pharmacological Comparison
- Midazolam is a water-soluble, short-acting benzodiazepine that is 1.5-3.5 times more potent than diazepam with a rapid onset of action (1-2 minutes) and shorter duration of effect (15-80 minutes) 2
- Lorazepam has a slower onset but longer duration of action compared to midazolam, making the conversion important for maintaining appropriate sedation levels 1
- The potency ratio indicates that lorazepam is approximately 2-2.5 times more potent than midazolam on a milligram-to-milligram basis 1, 3
Clinical Implications
When converting between these medications, consider that midazolam has:
Lorazepam provides:
Dosing Considerations
- For procedural sedation, midazolam is often preferred due to its rapid onset and shorter recovery time 5
- For longer-term sedation, lorazepam may be more appropriate due to its longer duration of action and more predictable sedation levels 4
- When converting from midazolam to lorazepam in critical care settings, an equipotent dose ratio of approximately 10:0.7 (midazolam:lorazepam) has been observed 4
Special Populations
- Elderly patients and those with hepatic or renal impairment require dose reductions for both medications 2
- Patients on concomitant CNS depressants may require lower doses of either medication due to synergistic effects 2
- When either medication is combined with opioids, dose reductions are necessary due to synergistic respiratory depression 2
Clinical Pearls
- Both medications can cause respiratory depression, with midazolam potentially causing apnea up to 30 minutes after administration 2
- Flumazenil can be used as an antidote for benzodiazepine-induced respiratory depression, but its duration of action (approximately 1 hour) may be shorter than the benzodiazepine effect, requiring monitoring for re-sedation 2
- When using either medication for acute agitation in the emergency department, both are considered effective as monotherapy 2